Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
British American Tobacco ( (GB:BATS) ) just unveiled an update.
British American Tobacco has repurchased 165,639 ordinary shares from Banco Santander under its ongoing buyback programme, paying a volume-weighted average price of 4,165.6818 pence and intending to cancel the stock. Following this latest transaction, the group will have 2,170,606,871 ordinary shares in issue with voting rights and 132,669,859 shares held in treasury, a change that may affect shareholder notification thresholds under UK disclosure rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
Spark’s Take on BATS Stock
According to Spark, TipRanks’ AI Analyst, BATS is a Outperform.
The score is driven primarily by solid-but-not-clean financial performance (profitability strength offset by leverage and a notable 2025 cash-flow decline). Valuation is supportive due to the high dividend yield and moderate P/E, while technicals are broadly neutral. Earnings-call guidance and capital-return plans help, but are tempered by vapor/illicit pressures and regional weakness.
To see Spark’s full report on BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. is a global tobacco group listed in London, producing and marketing cigarettes and other nicotine products across multiple regions. The company focuses on maintaining shareholder returns while managing a large base of ordinary shares, including stock held in treasury, and actively uses share buybacks as part of its capital allocation strategy.
Average Trading Volume: 4,710,462
Technical Sentiment Signal: Strong Buy
Current Market Cap: £91.44B
See more data about BATS stock on TipRanks’ Stock Analysis page.

